FDA Plan to Halt Counterfeits Includes Launch of Drug Tracking System

International Pharmaceutical Regulatory Monitor
KEYWORDS FDA / Technology
A A

Based on recommendations of a special task force charged with looking into the growing problem of counterfeit drugs, the FDA says it is now prepared to implement a long-anticipated system for overseeing drug products’ movement throughout the distribution chain.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $10.00